Delfi Diagnostics
Delfi Diagnostics
Claim
Delfi Diagnostics is committed to developing high-performing, affordable blood tests for early detection of cancer across multiple tumor types. Leveraging recent advances in cancer biology and machine learning, DELFI's technology can achieve high performance from low-cost, widely available sequencing technology.Delfi Diagnostics is committed to developing high-performing, affordable blood tests for early detec Show More
Alpha Score
$ 330.50 M
Alpha Score
70.3
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0